Human primary intestinal epithelial cells as an improved in vitro model for cryptosporidium parvum infection

Infection and Immunity

Volumn 81, Issue 6, 2013, Pages 1996-2001

  Castellanos Gonzalez, Alejandro ^a   Cabada, Miguel M ^a   Nichols, Joan ^a   Gomez, Guillermo ^b   White, A Clinton ^a  

^a Division of Infectious Diseases   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOREGULATION; CELL CULTURE; CELL MATURATION; CELL PROLIFERATION; CELL REGENERATION; CELL VIABILITY; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CULTURE MEDIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE CRYPT; INTESTINE EPITHELIUM CELL; PARASITE CULTIVATION; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 84877811759     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01131-12     Document Type: Article

References (33)

1. Sartor RB. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577-594.
2. Deng M, Rutherford MS, Abrahamsen MS. 2004. Host intestinal epithelial response to Cryptosporidium parvum. Adv. Drug Deliv. Rev. 56:869-884.
3. Ciarlet M, Estes MK. 2001. Interactions between rotavirus and gastrointestinal cells. Curr. Opin. Microbiol. 4:435-441.
4. Eckmann L. 2003. Mucosal defences against Giardia. Parasite Immunol. 25:259-270.
5. Hodges K, Gill R. 2010. Infectious diarrhea: cellular and molecular mechanisms. Gut Microbes 1:4-21.
6. Kothavade RJ. 2011. Challenges in understanding the immunopathogenesis of Cryptosporidium infections in humans. Eur. J. Clin. Microbiol. Infect. Dis. 30:1461-1472.
7. Feng H, Nie W, Sheoran A, Zhang Q, Tzipori S. 2006. Bile acids enhance invasiveness of Cryptosporidium spp. into cultured cells. Infect. Immun. 74:3342-3346.
8. Yang YL, Buck GA, Widmer G. 2010. Cell sorting-assisted microarray profiling of host cell response to Cryptosporidium parvum infection. Infect. Immun. 78:1040-1048.
9. Karanis P, Aldeyarbi HM. 2011. Evolution of Cryptosporidium in vitro culture. Int. J. Parasitol. 41:1231-1242.
10. Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP, Estes MK. 2004. Laboratory efforts to cultivate noroviruses. J. Gen. Virol. 85:79-87.
11. King BJ, Keegan AR, Robinson BS, Monis PT. 2011. Cryptosporidium cell culture infectivity assay design. Parasitology 138:671-681.
12. Hashim A, Mulcahy G, Bourke B, Clyne M. 2006. Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells. Infect. Immun. 74:99-107.
13. Kaeffer B. 2002. Mammalian intestinal epithelial cells in primary culture: a mini-review. In Vitro Cell Dev. Biol. Anim. 38:123-134.
14. Jung P, Sato T, Merlos-Suarez A, Barriga FM, Iglesias M, Rossell D, Auer H, Gallardo M, Blasco MA, Sancho Clevers EH, Batlle E. 2011. Isolation and in vitro expansion of human colonic stem cells. Nat. Med. 17:1225-1227.
15. Spence JR, Mayhew CN, Rankin SA, Kuhar MF, Vallance JE, Tolle K, Hoskins EE, Kalinichenko VV, Wells SI, Zorn AM, Shroyer NF, Wells JM. 2011. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470:105-109.
16. George MD, Wehkamp J, Kays RJ, Leutenegger CM, Sabir S, Grishina I, Dandekar S, Bevins CL. 2008. In vivo gene expression profiling of human intestinal epithelial cells: analysis by laser microdissection of formalin fixed tissues. BMC Genomics 9:209. doi:10.1186/1471-2164-9-209.
17. Murayama M, Okamoto R, Tsuchiya K, Akiyama J, Nakamura T, Sakamoto N, Kanai T, Watanabe M. 2009. Musashi-1 suppresses expression of Paneth cell-specific genes in human intestinal epithelial cells. J. Gastroenterol. 44:173-182.
18. Rochelle PA, De Leon R, Stewart MH, Wolfe RL. 1997. Comparison of primers and optimization of PCR conditions for detection of Cryptosporidium parvum and Giardia lamblia in water. Appl. Environ. Microbiol. 63:106-114.
19. Cai X, Woods KM, Upton SJ, Zhu G. 2005. Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro. Antimicrob. Agents Chemother. 49:4437-4442.
20. Fontaine M, Guillot E. 2003. Study of 18S rRNA and rDNA stability by real-time RT-PCR in heat-inactivated Cryptosporidium parvum oocysts. FEMS Microbiol. Lett. 226:237-243.
21. Tosini F, Agnoli A, Mele R, Gomez Morales MA, Pozio E. 2004. A new modular protein of Cryptosporidium parvum, with ricin B and LCCL domains, expressed in the sporozoite invasive stage. Mol. Biochem. Parasitol. 134:137-147.
22. Hofmann C, Obermeier F, Artinger M, Hausmann M, Falk W, Schoelmerich J, Rogler G, Grossmann J. 2007. Cell-cell contacts prevent anoikis in primary human colonic epithelial cells. Gastroenterology 132:587-600.
23. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters PJ, Clevers H. 2009. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459:262-265.
24. Vidal K, Serrant P, Schlosser B, van den Broek P, Lorget F, Donnet-Hughes A. 2004. Osteoprotegerin production by human intestinal epithelial cells: a potential regulator of mucosal immune responses. Am. J. Physiol. Gastrointest Liver Physiol. 287:G836-G844.
25. Castellanos-Gonzalez A, Yancey LS, Wang HC, Pantenburg B, Liscum KR, Lewis DE, White AC, Jr. 2008. Cryptosporidium infection of human intestinal epithelial cells increases expression of osteoprotegerin: a novel mechanism for evasion of host defenses. J. Infect. Dis. 197:916-923.
26. Toruner M, Fernandez-Zapico M, Sha JJ, Pham L, Urrutia R, Egan LJ. 2006. Antianoikis effect of nuclear factor-κB through upregulated expression of osteoprotegerin, BCL-2, and IAP-1. J. Biol. Chem. 281:8686-8696.
27. Ootani A, Li X, Sangiorgi E, Ho QT, Ueno H, Toda S, Sugihara H, Fujimoto K, Weissman IL, Capecchi MR, Kuo CJ. 2009. Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche. Nat. Med. 15:701-706.
28. Haramis AP, Begthel H, van den Born M, van Es J, Jonkheer S, Offerhaus GJ, Clevers H. 2004. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303:1684-1686.
29. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H. 2007. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449:1003-1007.
30. Peng L, Li ZR, Green RS, Holzman IR, Lin J. 2009. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J. Nutr. 139: 1619-1625.
31. Bai Z, Zhang Z, Ye Y, Wang S. 2010. Sodium butyrate induces differentiation of gastric cancer cells to intestinal cells via the PTEN/ phosphoinositide 3-kinase pathway. Cell Biol. Int. 34:1141-1145.
32. Dann SM, Wang HC, Gambarin KJ, Actor JK, Robinson P, Lewis DE, Caillat-Zucman S, White AC, Jr. 2005. Interleukin-15 activates human natural killer cells to clear the intestinal protozoan cryptosporidium. J. Infect. Dis. 192:1294-1302.
33. Upton SJ, Tilley M, Brillhart DB. 1994. Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines. FEMS Microbiol. Lett. 118:233-236.